Modèles transgéniques pour l'étude de la fonction ... - Epublications

Poellinger, L., Yoza, B. K. and Roeder, R. G. (1989). Functional cooperativity between
protein molecules bound at two distinct sequence elements of the immunoglobulin heavy-chain
promoter. Nature 337, 573-6.
Pogue, S. L. and Goodnow, C. C. (2000). Gene dose-dependent maturation and receptor
editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp
Med 191, 1031-44.
Popov, A. V., Zou, X., Xian, J., Nicholson, I. C. and Bruggemann, M. (1999). A
human immunoglobulin lambda locus is similarly well expressed in mice and humans. J Exp Med
189, 1611-20.
Preud'homme, J. L., Aucouturier, P., Touchard, G., Striker, L., Khamlichi, A. A.,
Rocca, A., Denoroy, L. and Cogne, M. (1994). Monoclonal immunoglobulin deposition disease
(Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int
46, 965-72.
Proudfoot, A. E., Fritchley, S., Borlat, F., Shaw, J. P., Vilbois, F., Zwahlen, C.,
Trkola, A., Marchant, D., Clapham, P. R. and Wells, T. N. (2001). The BBXB motif of
RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem
276, 10620-6.
Rada, C., Williams, G. T., Nilsen, H., Barnes, D. E., Lindahl, T. and Neuberger, M.
S. (2002). Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed
in UNG-deficient mice. Curr Biol 12, 1748-55.
Radaev, S. and Sun, P. D. (2001). Recognition of IgG by Fcgamma receptor. The role of
Fc glycosylation and the binding of peptide inhibitors. J Biol Chem 276, 16478-83.
Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H. R.
and Aguet, M. (1999). Deficient T cell fate specification in mice with an induced inactivation of
Notch1. Immunity 10, 547-58.
Raff, M. C., Sternberg, M. and Taylor, R. B. (1970). Immunoglobulin determinants on
the surface of mouse lymphoid cells. Nature 225, 553-4.
Rafi, A., Nagarkatti, M. and Nagarkatti, P. S. (1997). Hyaluronate-CD44 interactions
can induce murine B-cell activation. Blood 89, 2901-8.
Rajewsky, K. (1996). Clonal selection and learning in the antibody system. Nature 381,
751-8.
Raju, T. S., Briggs, J. B., Chamow, S. M., Winkler, M. E. and Jones, A. J. (2001).
Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of
glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry 40, 8868-
76.
Razi, N. and Varki, A. (1998). Masking and unmasking of the sialic acid-binding lectin
activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci U S A 95, 7469-74.
Reichsman, F., Smith, L. and Cumberledge, S. (1996). Glycosaminoglycans can
modulate extracellular localization of the wingless protein and promote signal transduction. J
Cell Biol 135, 819-27.
Reina-San-Martin, B., Chen, J., Nussenzweig, A. and Nussenzweig, M. C. (2007).
Enhanced intra-switch region recombination during immunoglobulin class switch recombination
in 53BP1-/- B cells. Eur J Immunol 37, 235-9.
Reth, M. (1989). Antigen receptor tail clue. Nature 338, 383-4.
Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N.,
Forveille, M., Dufourcq-Labelouse, R., Gennery, A. et al. (2000). Activation-induced cytidine
deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome
(HIGM2). Cell 102, 565-75.
Robey, E. (1999). Regulation of T cell fate by Notch. Annu Rev Immunol 17, 283-95.
171